Finoso Pharma Pvt. Ltd.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Finoso Pharma Pvt. Ltd. - overview

Location

Hyderabad, -, India

Primary Industry

Pharmaceuticals

About

Finoso Pharma is a full-service Formulation Research and Development services company.


Current Investors

Vivimed Labs Ltd.

Primary Industry

Pharmaceuticals

Sub Industries

Pharmaceutical Research & Development

Website

www.finoso.com

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Finoso Pharma Pvt. Ltd. - financials

Fiscal Year EndedMar 31, 2013Mar 31, 2014Mar 31, 2015Mar 31, 2016Mar 31, 2017Mar 31, 2018Mar 31, 2019Mar 31, 2020Mar 31, 2021Mar 31, 2022Mar 31, 2023Mar 31, 2024
Revenue (USD)-65,888,03963,430,48068,834,79568,728,40099,870,011136,564,996243,669,980127,656,280---
% Revenue Growth (YoY)--(3.7%)8.5%(0.2%)45.3%36.7%78.4%(47.6%)---
EBITDA (USD)11,414,55912,532,4327,878,12110,373,32210,648,48220,724,37322,103,13638,365,37012,866,830---
Operating Income (USD)3,336,6364,600,4001,608,6263,762,8745,891,01515,883,39516,458,56726,720,140(109,650)---
Operating Margin-7.0%2.5%5.5%8.6%15.9%12.1%11.0%(0.1%)---
% EBITDA Margin-19.0%12.4%15.1%15.5%20.8%16.2%15.7%10.1%---
NET Income (USD)254,202426,849238,897(920,354)611,3348,567,7008,782,54415,942,220(4,909,820)---
% Net Margin-0.6%0.4%(1.3%)0.9%8.6%6.4%6.5%(3.8%)---

Finoso Pharma Pvt. Ltd. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-onCompletedFinoso Pharma Pvt. Ltd.-

Displaying 1 - 1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.